近红外荧光成像监测ENO1 mAb在宫颈癌荷瘤小鼠体内生物分布的研究

doi:10.7517/issn.1674-0475.230808

影像科学与光化学 ›› 2023, Vol. 41 ›› Issue (6): 350-357.DOI: 10.7517/issn.1674-0475.230808

近红外荧光成像监测ENO1 mAb在宫颈癌荷瘤小鼠体内生物分布的研究

赵调红^1,2, 章婷婷^1,2, 陈圆圆^1,2, 路如霞^1,2, 赵源旭^1,2, 裴亚萍², 刘会玲², 祝秉东³

1. 甘肃中医药大学第一临床医学院, 甘肃兰州 730000;
2. 甘肃省人民医院妇科, 甘肃兰州 730000;
3. 兰州大学基础医学院, 甘肃兰州 730000

收稿日期:2023-08-18 出版日期:2023-11-23 发布日期:2023-12-14
通讯作者: 刘会玲, 祝秉东
基金资助:
国家自然科学基金地区基金（82260557），北京科创医学发展基金会肿瘤研究基金面上项目（KC2021-JX-0186-141）

Study on the Biological Distribution of ENO1 mAb in Cervical Cancer Bearing Mice Monitored by Near Infrared Fluorescence Imaging

ZHAO Tiaohong^1,2, ZHANG Tingting^1,2, CHEN Yuanyuan^1,2, LU Ruxia^1,2, ZHAO Yuanxu^1,2, PEI Yaping², LIU Huiling², ZHU Bingdong³

1. The First Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, Gansu, P. R. China;
2. Department of Gynecology, Gansu Provincial Hospital, Lanzhou 730000, Gansu, P. R. China;
3. School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, Gansu, P. R. China

Received:2023-08-18 Online:2023-11-23 Published:2023-12-14

摘要/Abstract

摘要： 本研究探讨近红外荧光成像（NIRF）观察烯醇化酶1（ENO1）单克隆抗体（mAb）在宫颈癌荷瘤小鼠体内的分布、代谢及肿瘤靶向效率。利用癌症基因组图谱分析ENO1的表达与肿瘤分期和预后以及肿瘤免疫浸润的关系；Cy7-NHS和FITC与ENO1 mAb偶联成Cy7-ENO1 mAb和FITC-ENO1 mAb，通过激光共聚焦显微镜验证ENO1 mAb在宫颈癌细胞TC-1的定位，并建立宫颈癌皮下肿瘤模型，尾静脉注射Cy7-ENO1 mAb后在1、6、24、48、72和120 h进行近红外荧光成像，成像24 h后迅速解剖主要脏器进行体外成像。生物信息学分析结果表明ENO1在正常宫颈组织与宫颈癌组织中的表达有显著差异，免疫组织化学（IHC）结果提示ENO1蛋白在宫颈癌组织中高表达；此外，其表达与肿瘤分期和淋巴结分期显著相关，并且ENO1的高表达与多种糖酵解酶相关；激光共聚焦显微镜扫描显示FITC-ENO1 mAb能特异性结合在TC-1细胞膜表面，细胞未见内化；近红外荧光成像证明Cy7-ENO1 mAb主要富集在肝脏、肾脏和肿瘤组织，并且具有较高的肿瘤靶向效率。NIRF成像可以实时、动态监测ENO1 mAb在宫颈癌荷瘤小鼠体内的分布，其代谢器官主要是肝脏和肾脏，并且证实ENO1 mAb具有靶向宫颈癌作用。

关键词: 近红外荧光成像, ENO1 mAb, 生物分布, Cy7-NHS

Abstract: In this study, the distribution, metabolism and tumor targeting efficiency of Enolase 1 (ENO1) monoclonal antibody (mAb) in cervical cancer bearing mice were investigated by near infrared fluorescence imaging. The relationship between ENO1 expression and tumor stage, prognosis and tumor immune invasion was analyzed by cancer genome atlas. Cy7-NHS and FITC were coupled with ENO1 mAb to form Cy7-ENO1 mAb and FITC-ENO1 mAb, and the localization of ENO1 mAb in cervical cancer cell TC-1 was verified by laser confocal microscopy, and the subcutaneous tumor model of cervical cancer was established. Near infrared fluorescence (NIRF) imaging was performed at 1, 6, 24, 48, 72, and 120 h after caudal intravenous injection of Cy7-ENO1 mAb. After 24 h of imaging, major organs were rapidly dissected for in vitro imaging. Bioinformatics results showed significant differences in the expression of ENO1 between normal cervical tissue and cervical cancer tissue while immunohistochemistry (IHC) indicated higher ENO1 protein expression in cervical cancer tissues. In addition, the expression of ENO1 was significantly correlated with tumor stage and lymph node stage, and the high expression of ENO1 was correlated with multiple glycolytic enzymes. Confocal laser microscopy showed that FITC-ENO1 mAb could specifically bind to the surface of TC-1 cell membrane, and no cell internalization was observed. Near infrared fluorescence imaging showed that Cy7-ENO1 mAb was mainly enriched in liver, kidney and tumor tissues, and had high tumor targeting efficiency. NIRF imaging allows real-time and dynamic monitoring of ENO1 mAb distribution in cervical cancer bearing mice, whose metabolic organs are mainly liver and kidney, and confirms ENO1 mAb's targeting of cervical cancer.

Key words: near infrared fluorescence imaging, ENO1 mAb, biodistribution, Cy7-NHS

赵调红, 章婷婷, 陈圆圆, 路如霞, 赵源旭, 裴亚萍, 刘会玲, 祝秉东. 近红外荧光成像监测ENO1 mAb在宫颈癌荷瘤小鼠体内生物分布的研究[J]. 影像科学与光化学, 2023, 41(6): 350-357.

ZHAO Tiaohong, ZHANG Tingting, CHEN Yuanyuan, LU Ruxia, ZHAO Yuanxu, PEI Yaping, LIU Huiling, ZHU Bingdong. Study on the Biological Distribution of ENO1 mAb in Cervical Cancer Bearing Mice Monitored by Near Infrared Fluorescence Imaging[J]. IMAGING SCIENCE AND PHOTOCHEMISTRY, 2023, 41(6): 350-357.

参考文献

[1] Zuo J H, Wang B W, Long M, et al. The type 1 transmembrane glycoprotein B7-H3 interacts with the glycolytic enzyme ENO1 to promote malignancy and glycolysis in HeLa cells[J]. FEBS Letters, 2018, 592(14):2476-2488.
[2] Dammes N, Peer D. Monoclonal antibody-based molecular imaging strategies and theranostic opportunities[J]. Theranostics, 2020, 10(2):938-955.
[3] Lin M, Paolillo V, Le D B, et al. Monoclonal antibody based radiopharmaceuticals for imaging and therapy[J]. Current Problems in Cancer, 2021, 45(5):100796.
[4] 张胜华, 程昕, 钟根深,等. 活体成像分析异硫氰酸荧光素标记Rituximab在荷淋巴瘤裸鼠体内的生物分布[J]. 中华医学杂志, 2010, 90(33):2367-2370.
[5] Gou Y F, Li F, Huo X Q, et al. ENO1 monoclonal antibody inhibits invasion, proliferation and clone formation of cervical cancer cells[J]. American Journal of Cancer Research, 2021, 11(5):1946-1961.
[6] Zhang C, Ling X Y, Guo Y X, et al. Evaluation of COC183B2 antibody targeting ovarian cancer by near-infrared fluorescence imaging[J]. Chinese Journal of Cancer Research, 2019, 31(4):673-685.
[7] Siegel R L, Miller K D, Fuchs H E, et al. Cancer Statistics, 2021[J]. CA:A Cancer Journal For Clinicians, 2021, 71(1):7-33.
[8] Arbyn M, Weideprass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018:A worldwide analysis[J]. The Lancet Global Health, 2020, 8(2):e191-e203.
[9] Liang Y K, Wang H, Chen B, et al. circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression[J]. Molecular Therapy-Nucleic Acids, 2021, 23:355-368.
[10] Sedoris K C, Thomas S D, Miller D M. C-myc promoter binding protein regulates the cellular response to an altered glucose concentration[J]. Biochemistry, 2007, 46(29):8659-8668.
[11] Kang M, Abdelmageed H, Lee S, et al. AtMBP-1, an alternative translation product of LOS2, affects abscisic acid responses and is modulated by the E3 ubiquitin ligase AtSAP5[J]. The Plant Journal:for Cell and Molecular Biology, 2013, 76(3):481-493.
[12] Principe M, Borgoni S, Cascione M, et al. Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis[J]. Journal of Hematology & Oncology, 2017, 10(1):16.
[13] Yin H, Wang L, Liu H L. ENO1 overexpression in pancreatic cancer patients and its clinical and diagnostic significance[J]. Gastroenterology Research and Practice, 2018, 2018:3842198.
[14] Zhan P P, Wang Y L, Zhao S H, et al. FBXW7 negatively regulates ENO1 expression and function in colorectal cancer[J]. Laboratory Investigation, 2015, 95(9):995-1004.
[15] Expression of Concern:Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating β-catenin[J].Bioscience Reports, 2021, 41(2):BSR20190503.
[16] Zhang L H, Wang H B, Dong X J. Diagnostic value of α-enolase expression and serum α-enolase autoantibody levels in lung cancer [J]. Jornal Brasileiro de Pneumologia, 2018, 44(1):18-23.
[17] Qiao H, Wang Y F, Yuan W Z, et al. Silencing of ENO1 by shRNA inhibits the proliferation of gastric cancer cells[J]. Technology in Cancer Research Treatment, 2018, 17:153303381878441.
[18] Hoang A T, Vizio B, Chiusa L, et al. Impact of tissue enolase 1 protein overexpression in esophageal cancer progression[J]. International Journal of Medical Sciences, 2021, 18(6):1406-1414.
[19] Tang B, Cui L J, Xu K H, et al. A sensitive and selective near-infrared fluorescent probe for mercuric ions and its biological imaging applications[J]. ChemBioChem, 2008, 9(7):1159-1164.
[20] Cheson B D, Leonard J P. Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma[J]. New England Journal of Medicine, 2008, 359(6):613-626.

近红外荧光成像监测ENO1 mAb在宫颈癌荷瘤小鼠体内生物分布的研究

Study on the Biological Distribution of ENO1 mAb in Cervical Cancer Bearing Mice Monitored by Near Infrared Fluorescence Imaging

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价